glp-1 and weight loss Patients' Use Drugs for Loss, Benefit Gains Studies Show GLP-1 Weight-Loss Drugs

Both groups exhibited similar reductions in body weight up to 72 h post-G49 injection

Effects of Glucagon-Like Peptide-1 Receptor Agonists Liraglutide and Semaglutide on Cardiovascular and Renal Outcomes Across Body Mass Index Categories in Type 2 Diabetes: Results of the LEADER and SUSTAIN 6 Trials

Phase one (weeks 1 through 4): establish baseline digestive stability with psyllium or methylcellulose

National Center for Biotechnology Information

The aim of this study was to clarify in prospective study whether long-term zinc supplementation improves prognosis, inhibits HCC development, and suppresses deterioration of liver function in patients with cirrhosis after administration of zinc acetate (Novelzin), which can be used in daily clinical practice

S.Van OudenhoveL.WhiteheadW